Entera Bio Ltd.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Jerusalem
ENTX chart
What traders are saying about $ENTX
Latest postsEntera Bio Ltd. news
- Entera Bio at guggenheim healthcare conference: oral bone drug nears phase III
Investing.com Nigeria ·
- Weekly Recap: Late-2026 EB613 Phase 3 trial plan and wider Q3 loss
TradingView ·
- How Is Entera Bio Ltd. (NASDAQ:ENTX) Preparing Its EB613 Phase 3 Osteoporosis Trial?
Kalkine ·
- Entera Bio Posts $15.6M Q3 Loss, $265.9M Cash Funds EB613 Phase 3 Into 2030
Minichart ·
- Entera Bio Q3FY26 Results: Net loss widens to $15.6M, cash at $265.9M
scanx.trade ·
- Entera Bio Reports Third-Quarter Results, Advances Osteoporosis Programs
TipRanks ·
- Entera Bio Ltd. (ENTX) Misses Q3 EPS by 4c
StreetInsider ·
- Entera Bio 3Q 2026: Revenue $0, EPS ($0.11) — 10-Q Summary
TradingView ·
- Entera Bio Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Entera Announces Third Quarter 2026 Financial Results and Business Updates
Yahoo Finance ·
- Why Is Entera Bio (NASDAQ:ENTX) Down 7.87% Pre-Market Despite Its USD 275.0 million Placement?
Kalkine ·
- Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
Yahoo Finance ·
Entera Bio Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $42,000 | $181,000 | $0 | $134,000 |
| Net income | -$11.4M | -$9.5M | -$8.9M | -$13.1M |
| Diluted EPS | $0.25 | $0.25 | $0.31 | $0.45 |
| Total assets (year end) | $16.0M | $9.4M | $11.8M | $13.1M |
| Cash and equivalents (year end) | $7.1M | $8.7M | $11.0M | $12.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Entera Bio Ltd.
- Ticker
- ENTX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Jerusalem
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1638097
Frequently asked questions
What exchange is Entera Bio Ltd. listed on?
Entera Bio Ltd. trades on the Nasdaq under the ticker symbol ENTX.
What industry is Entera Bio Ltd. in?
Entera Bio Ltd. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Entera Bio Ltd. headquartered?
Entera Bio Ltd.'s business address on file with the SEC is in Jerusalem.
When does Entera Bio Ltd.'s fiscal year end?
Entera Bio Ltd.'s fiscal year ends on December 31.
How much revenue did Entera Bio Ltd. report?
Entera Bio Ltd. reported $42,000 in revenue for calendar year 2025, according to its SEC filings.